"Squalenoylcurcumin" Nanoassemblies as Water-Dispersible Drug Candidates with Antileishmanial Activity

被引:21
作者
Cheikh-Ali, Zakaria [1 ]
Caron, Joachim [2 ]
Cojean, Sandrine [3 ]
Bories, Christian [3 ]
Couvreur, Patrick [2 ]
Loiseau, Philippe M. [3 ]
Desmaele, Didier [2 ]
Poupon, Erwan [1 ]
Champy, Pierre [1 ]
机构
[1] Univ Paris 11, Lab Pharmacognosie, CNRS UMR BioCIS LabEX LERMIT 8076, Fac Pharm, F-92296 Chatenay Malabry, France
[2] Univ Paris 11, Inst Galien, CNRS UMR 8612, Fac Pharm, F-92296 Chatenay Malabry, France
[3] Univ Paris 11, Fac Pharm, CNRS UMR BioCIS LabEX LERMIT 8076, F-92296 Chatenay Malabry, France
基金
欧洲研究理事会;
关键词
biological activity; curcumin; drug discovery; nanoparticles; squalenoylation; SEE VOL. 102; CELLULAR UPTAKE; IN-VITRO; CURCUMIN NANOFORMULATIONS; ENCAPSULATED CURCUMIN; PLGA NANOPARTICLES; DELIVERY; CANCER; BIOAVAILABILITY; FORMULATION;
D O I
10.1002/cmdc.201402449
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Curcumin, a natural polyphenolic compound, showed antiparasitic potential, including trypanocidal and leishmanicidal activity, in several in vitro and in vivo models. The molecule is well tolerated in humans. However, it is insoluble in water and displays poor oral bioavailability as a result of low absorption. New derivatives of curcumin were prepared by esterification of one or two of its phenolic groups with 1,1',2-tris-norsqualenic acid. These "squalenoylcurcumins" were formulated as water-dispersible nanoassemblies of homogeneous size, and they proved to be stable. Squalenoylcurcumins were inactive against Trypanosoma brucei brucei trypomastigotes, even as nanoassemblies, in contrast with curcumin. However, against Leishmania donovani promastigotes, the activities of the squalenoylcurcumins and their nanoassemblies were enhanced relative to that of curcumin. In L. donovani axenic and intramacrophagic amastigotes, they showed activity in the range of miltefosine, with good selectivity indexes. In regard to their dispersibility in water and to the safety of curcumin, these nanoassemblies are promising candidates for preclinical study toward the treatment of visceral leishmaniasis.
引用
收藏
页码:411 / 418
页数:8
相关论文
共 85 条
[1]   Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model [J].
Adapala, Nagasuresh ;
Chan, Marion M. .
LABORATORY INVESTIGATION, 2008, 88 (12) :1329-1339
[2]   Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets [J].
Aggarwal, Bharat B. ;
Sung, Bokyung .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (02) :85-94
[3]  
Alves LV, 2003, BIOL PHARM BULL, V26, P453, DOI 10.1248/bpb.26.453
[4]   Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[5]   RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo (Retracted article. See vol. 102, pg. 143, 2016) [J].
Anand, Preetha ;
Nair, Hareesh B. ;
Sung, Bokyung ;
Kunnumakkara, Ajaikumar B. ;
Yadav, Vivek R. ;
Tekmal, Rajeshwar R. ;
Aggarwal, Bharat B. .
BIOCHEMICAL PHARMACOLOGY, 2010, 79 (03) :330-338
[6]  
[Anonymous], 2014, Leishmaniasis
[7]  
[Anonymous], 1999, WHO MONOGRAPHS SELEC
[8]  
[Anonymous], 2012, TRYP HUM AFR SLEEP S
[9]   Studies on the effectiveness of diarylheptanoids derivatives against Leishmania amazonensis [J].
Araujo, CAC ;
Alegrio, LV ;
Gomes, DCF ;
Lima, MEF ;
Gomes-Cardoso, L ;
Leon, LL .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1999, 94 (06) :791-794
[10]   Squalene Based Nanocomposites: A New Platform for the Design of Multifunctional Pharmaceutical Theragnostics [J].
Arias, Jose L. ;
Reddy, L. Harivardhan ;
Othman, Mohammad ;
Gillet, Brigitte ;
Desmaele, Didier ;
Zouhiri, Fatima ;
Dosio, Franco ;
Gref, Ruxandra ;
Couvreur, Patrick .
ACS NANO, 2011, 5 (02) :1513-1521